尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the detailed record of transactions filed by Fasola Kenneth J, 首席执行官. Director active across 2 companies, notably Magellan Health INC. In total, 10 reports have been published. Breakdown: 0 buy · 2 sells. Total volume traded: €1.1m. History available since 2 December 2021. The latest transaction was disclosed on 4 July 2024 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 条申报中的 10 条
FASOLA KENNETH J is Directeur Général, and is associated with CENTENE CORP as President and with Magellan Health INC as Chief Executive Officer. He has 10 filings in total, and across the 10 sampled filings between 2021-12-06 and 2024-07-05, sales total 1145026 EUR, with the dominant transaction nature shown as Retenue fiscale.